Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis

NCT07235904 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis (UC)

Interventions

DRUG: Mirikizumab
DRUG: Azathioprine (AZA)

Sponsor

University Hospital Schleswig-Holstein